Physician profile
Fran J Webb
NPI 1902397672
$8,532.19
in general payments reported to CMS, 2019-2025
35 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $1,735 · 2023: $1,457 · 2024: $3,610 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,254 · Travel and Lodging: $994 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,254.27 |
| Travel and Lodging | $993.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $117.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,797.00 | 2021-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Axonics |
| Axonics, INC. | $2,382.69 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $570.45 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $388.72 | 2021-2024 | Xtandi, Veozah |
| Endo Pharmaceuticals INC. | $262.19 | 2021-2023 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $255.59 | 2024-2025 | Aquabeam System |
| Urovant Sciences INC | $187.15 | 2021-2022 | |
| Janssen Biotech, INC. | $173.05 | 2021-2025 | Erleada, Akeega |
| Angiodynamics, INC. | $162.67 | 2024-2025 | Nanoknife |
| Pfizer INC. | $130.34 | 2024-2025 | |
| Antares Pharma, INC. | $126.90 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $116.11 | 2023-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $105.12 | 2022-2023 | Prolaris |
| Tolmar, INC. | $102.24 | 2023-2025 | Jatenzo |
| Olympus America INC. | $80.85 | 2021-2025 | Itind System, Cysto-Nephro Videoscope |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $62.06 | 2022-2024 | Urgent PC Neuromodulation System |
| Halozyme INC | $60.63 | 2023 | |
| Teleflex LLC | $57.08 | 2021-2023 | Urolift |
| Coloplast Corp | $54.99 | 2023-2024 | Porges Coloplast |
| C. R. Bard, INC. & Subsidiaries | $51.98 | 2024-2025 | Bard Urinary Drainage Bag |
| Endo USA, INC. | $46.35 | 2024 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $45.33 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.67 | 2024-2025 | |
| Ethicon US, LLC | $38.39 | 2025 | Vistaseal, Ethicon, Evarrest |
| Ferring Pharmaceuticals INC. | $34.79 | 2025 | Adstiladrin |
| Abbvie INC. | $30.75 | 2023-2025 | |
| Becton, Dickinson and Company | $28.34 | 2025 | Bard Urinary Drainage Bag |
| Rochester Medical Corporation | $27.87 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.27 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.80 | 2023 | |
| Calyxo, INC. | $20.44 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $14.88 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.36 | 2023 | Seglentis |
| Myovant Sciences INC. | $11.65 | 2021 | |
| Travere Therapeutics, INC. | $2.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fran Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.